Gelteq (GELS) Prices 1.3M Share IPO at $4/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Gelteq Limited Prices US$5.2 Million Initial Public Offering
October 28, 2024 9:50 PM EDTNEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (Gelteq or the Company), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today that it has priced its initial public offering of 1,300,000 ordinary shares of the Company at a public offering price of US$4.00 per share. The shares have been approved for listing on the Nasdaq Capital Market (Nasdaq). Trading on Nasdaq is expected to begin on October 29, 2024 under the symbol GELS.
The gross proceeds from the offering, before deducting underwriting fees and other offering expenses payable by the... More
